Analyst Consensus ?
ConsensusHold41 ratings
Bullish2253.7%
Neutral1639.0%
Bearish37.3%
FN2 Earnings Intelligence
Amgen Inc. complete analyst coverage
Amgen Inc. (AMGN) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$378.99Current
$182Low
$337.91Average
$460High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 11, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| HSBC | Hold | Buy | Downgrade | Sep 10, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Sep 8, 2026 |
| BMO Capital | Market Perform | Outperform | Downgrade | Sep 8, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Sep 4, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 20, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 19, 2026 |
| Argus Research | Buy | Buy | Maintain | Aug 19, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Aug 18, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Aug 14, 2026 |
| Guggenheim | Neutral | Neutral | Maintain | Aug 10, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 7, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Aug 6, 2026 |
| UBS | Buy | Buy | Maintain | Aug 5, 2026 |
| Truist Securities | Hold | Hold | Maintain | Aug 5, 2026 |
| TD Cowen | Buy | Buy | Maintain | Aug 5, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Aug 5, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 5, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 5, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Aug 5, 2026 |
| Canaccord Genuity | Hold | Hold | Maintain | Aug 5, 2026 |
| Baird | Underperform | Underperform | Maintain | Aug 5, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Aug 5, 2026 |
| Freedom Broker | Hold | Buy | Downgrade | Feb 12, 2026 |
| Leerink Partners | Outperform | Outperform | Maintain | Feb 4, 2026 |
| Jefferies | Buy | Buy | Maintain | Nov 12, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Aug 7, 2024 |
| William Blair | Outperform | Market Perform | Upgrade | May 3, 2024 |
| Daiwa Capital | Buy | Neutral | Upgrade | Dec 21, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 12, 2023 |
| SVB Leerink | Market Perform | Market Perform | Maintain | Feb 2, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 1, 2023 |
| Atlantic Equities | Underweight | Underweight | Maintain | Aug 9, 2022 |
| Raymond James | Outperform | Market Perform | Upgrade | Oct 26, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jul 30, 2020 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 29, 2020 |
| CFRA | Buy | Buy | Maintain | May 1, 2020 |
| Evercore ISI Group | Outperform | In Line | Upgrade | Jan 21, 2020 |
| PiperJaffray | Overweight | Overweight | Maintain | Jul 27, 2018 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| Bank of America | Buy | Neutral | Upgrade | Feb 1, 2017 |
| Nomura | Buy | Buy | Maintain | Sep 22, 2015 |
Named analyst price targets
Upside is calculated against the persisted current price $378.99. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Mohit Bansal | $435 | $444.12 | +14.8% | Sep 4, 2026 |
| Piper Sandler | David Amsellem | $457 | $442.36 | +20.6% | Aug 20, 2026 |
| Morgan Stanley | Analyst unavailable | $362 | $440.28 | -4.5% | Aug 19, 2026 |
| Argus Research | Analyst unavailable | $460 | $439.95 | +21.4% | Aug 19, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $400 | $419.38 | +5.5% | Aug 18, 2026 |
| Mizuho Securities | Analyst unavailable | $352 | $419.38 | -7.1% | Aug 18, 2026 |
| Barclays | Emily Field | $380 | $417.84 | +0.3% | Aug 14, 2026 |
| Guggenheim | Vamil Divan | $388 | $410.94 | +2.4% | Aug 10, 2026 |
| Bernstein | Analyst unavailable | $345 | $407.83 | -9.0% | Aug 6, 2026 |
| Scotiabank | Louise Chen | $450 | $406.25 | +18.7% | Aug 5, 2026 |
| Oppenheimer | Analyst unavailable | $450 | $390.02 | +18.7% | Aug 5, 2026 |
| RBC Capital | Analyst unavailable | $400 | $390.02 | +5.5% | Aug 5, 2026 |
| Robert W. Baird | Brian Skorney | $230 | $390.02 | -39.3% | Aug 5, 2026 |
| Canaccord Genuity | Gary Nachman | $384 | $390.02 | +1.3% | Aug 5, 2026 |
| BMO Capital | Evan Seigerman | $450 | $390.02 | +18.7% | Aug 5, 2026 |
| Barclays | Emily Field | $360 | $393.1 | -5.0% | Jul 29, 2026 |
| UBS | Analyst unavailable | $420 | $358.68 | +10.8% | Jul 13, 2026 |
| Guggenheim | Analyst unavailable | $343 | $363.39 | -9.5% | Jul 13, 2026 |
| Morgan Stanley | Analyst unavailable | $333 | $368.1 | -12.1% | Jul 8, 2026 |
| BMO Capital | Evan David Seigerman | $400 | $362.45 | +5.5% | Jul 1, 2026 |
| Mizuho Securities | Salim Syed | $303 | $350.53 | -20.1% | Jun 16, 2026 |
| Morgan Stanley | Analyst unavailable | $340 | $344.56 | -10.3% | Jun 9, 2026 |
| Goldman Sachs | Analyst unavailable | $389 | $352.62 | +2.6% | Jun 5, 2026 |
| Piper Sandler | Analyst unavailable | $427 | $336.45 | +12.7% | May 14, 2026 |
| Guggenheim | Analyst unavailable | $340 | $329.82 | -10.3% | May 4, 2026 |
| Morgan Stanley | Analyst unavailable | $332 | $329.3 | -12.4% | May 1, 2026 |
| Canaccord Genuity | Analyst unavailable | $366 | $350.16 | -3.4% | Apr 20, 2026 |
| Morgan Stanley | Terence Flynn | $326 | $352.59 | -14.0% | Apr 10, 2026 |
| Guggenheim | Analyst unavailable | $351 | $355.6 | -7.4% | Apr 9, 2026 |
| Truist Financial | Analyst unavailable | $325 | $349.81 | -14.2% | Apr 8, 2026 |
| Jefferies | Akash Tewari | $350 | $373.08 | -7.6% | Mar 10, 2026 |
| Leerink Partners | David Risinger | $355 | $367.6 | -6.3% | Mar 5, 2026 |
| Barclays | Analyst unavailable | $185 | $375.5 | -51.2% | Feb 19, 2026 |
| Wells Fargo | Analyst unavailable | $375 | $379.73 | -1.1% | Feb 19, 2026 |
| Piper Sandler | Analyst unavailable | $432 | $373.36 | +14.0% | Feb 18, 2026 |
| Mizuho Securities | Analyst unavailable | $295 | $364.65 | -22.2% | Feb 11, 2026 |
| RBC Capital | Analyst unavailable | $360 | $357.29 | -5.0% | Feb 4, 2026 |
| Morgan Stanley | Analyst unavailable | $309 | $351.81 | -18.5% | Feb 4, 2026 |
| Oppenheimer | Analyst unavailable | $400 | $343.57 | +5.5% | Jan 29, 2026 |
| UBS | Analyst unavailable | $390 | $348.99 | +2.9% | Jan 26, 2026 |
| Bernstein | Market Perform | $335 | $330.44 | -11.6% | Jan 20, 2026 |
| UBS | Analyst unavailable | $380 | $330.17 | +0.3% | Jan 6, 2026 |
| Morgan Stanley | Analyst unavailable | $304 | $317.67 | -19.8% | Dec 12, 2025 |
| HSBC | Analyst unavailable | $425 | $313.85 | +12.1% | Dec 10, 2025 |
| BMO Capital | Evan Seigerman | $372 | $338.36 | -1.8% | Dec 3, 2025 |
| Wells Fargo | Analyst unavailable | $400 | $334.3 | +5.5% | Nov 25, 2025 |
| Truist Financial | Analyst unavailable | $318 | $336.2 | -16.1% | Nov 24, 2025 |
| Piper Sandler | David Amsellem | $381 | $332.43 | +0.5% | Nov 14, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $315 | $318.4 | -16.9% | Nov 6, 2025 |
| Wells Fargo | Analyst unavailable | $300 | $296.7 | -20.8% | Nov 5, 2025 |
| Piper Sandler | Analyst unavailable | $342 | $288.47 | -9.8% | Aug 25, 2025 |
| UBS | Trung Huynh | $315 | $281.22 | -16.9% | May 2, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $305 | $278.4 | -19.5% | Apr 22, 2025 |
| Johnson Rice | Analyst unavailable | $294 | $316.57 | -22.4% | Mar 5, 2025 |
| Jefferies | Michael Yee | $380 | $298.84 | +0.3% | Nov 12, 2024 |
| Cantor Fitzgerald | Olivia Brayer | $405 | $298.84 | +6.9% | Nov 12, 2024 |
| Morgan Stanley | Terence Flynn | $319 | $316.74 | -15.8% | Oct 21, 2024 |
| Goldman Sachs | Salveen Richter | $369 | $325.09 | -2.6% | Oct 16, 2024 |
| Barclays | Carter Gould | $315 | $319.66 | -16.9% | Oct 7, 2024 |
| BMO Capital | Evan David Seigerman | $362 | $330.92 | -4.5% | Sep 25, 2024 |
| Raymond James | Christopher Raymond | $344 | $330.92 | -9.2% | Sep 25, 2024 |
| Robert W. Baird | Brian Skorney | $215 | $330.92 | -43.3% | Sep 25, 2024 |
| Wells Fargo | Mohit Bansal | $335 | $328.95 | -11.6% | Aug 7, 2024 |
| Morgan Stanley | Terence Flynn | $303 | $330.78 | -20.1% | Aug 6, 2024 |
| RBC Capital | Gregory Renza | $332 | $298.71 | -12.4% | Jun 14, 2024 |
| Oppenheimer | Jay Olson | $380 | $312.32 | +0.3% | May 17, 2024 |
| Mizuho Securities | Salim Syed | $235 | $307.31 | -38.0% | May 9, 2024 |
| Morgan Stanley | Terence Flynn | $310 | $315.19 | -18.2% | May 3, 2024 |
| BMO Capital | Evan David Seigerman | $355 | $278.39 | -6.3% | May 3, 2024 |
| UBS | Colin Bristow | $307 | $278.39 | -19.0% | May 3, 2024 |
| Barclays | Carter Gould | $300 | $278.39 | -20.8% | May 3, 2024 |
| Wells Fargo | Mohit Bansal | $320 | $265.1 | -15.6% | Apr 17, 2024 |
| Oppenheimer | Jay Olson | $280 | $260.31 | -26.1% | Sep 13, 2023 |
| Wells Fargo | Mohit Bansal | $265 | $251.08 | -30.1% | Apr 12, 2023 |
| Wells Fargo | Mohit Bansal | $275 | $228.84 | -27.4% | Mar 10, 2023 |
| Leerink Partners | Analyst unavailable | $267 | $246.41 | -29.5% | Feb 2, 2023 |
| RBC Capital | Analyst unavailable | $258 | $242.92 | -31.9% | Feb 1, 2023 |
| Oppenheimer | Analyst unavailable | $294 | $243.8 | -22.4% | Feb 1, 2023 |
| Cowen & Co. | Analyst unavailable | $289 | $243.47 | -23.7% | Feb 1, 2023 |
| BMO Capital | Analyst unavailable | $253 | $252.4 | -33.2% | Feb 1, 2023 |
| Wells Fargo | Analyst unavailable | $285 | $260.67 | -24.8% | Jan 3, 2023 |
| Leerink Partners | Analyst unavailable | $282 | $266.26 | -25.6% | Dec 22, 2022 |
| Piper Sandler | Analyst unavailable | $299 | $276.78 | -21.1% | Dec 13, 2022 |
| Oppenheimer | Analyst unavailable | $310 | $285.59 | -18.2% | Dec 6, 2022 |
| Raymond James | Christopher Raymond | $297 | $285.72 | -21.6% | Dec 5, 2022 |
| Credit Suisse | Analyst unavailable | $240 | $287.3 | -36.7% | Nov 18, 2022 |
| Barclays | Carter Gould | $234 | $273.81 | -38.3% | Oct 31, 2022 |
| Atlantic Equities | Analyst unavailable | $182 | $247.29 | -52.0% | Aug 9, 2022 |
| RBC Capital | Analyst unavailable | $236 | $246.98 | -37.7% | Aug 5, 2022 |
| Piper Sandler | Analyst unavailable | $265 | $246.98 | -30.1% | Aug 5, 2022 |
| Morgan Stanley | Analyst unavailable | $253 | $247.87 | -33.2% | Jul 15, 2022 |
| Oppenheimer | Jay Olson | $290 | $248.94 | -23.5% | Jun 3, 2022 |
| Mizuho Securities | Salim Syed | $208 | $239.24 | -45.1% | May 10, 2022 |
| BMO Capital | Evan Seigerman | $243 | $238.13 | -35.9% | Apr 29, 2022 |
| Barclays | Carter Gould | $236 | $254.02 | -37.7% | Apr 16, 2022 |
| BMO Capital | Evan David Seigerman | $240 | $220.77 | -36.7% | Feb 21, 2022 |
| UBS | Colin Bristow | $232 | $238.96 | -38.8% | Feb 8, 2022 |
| Piper Sandler | Christopher Raymond | $255 | $238.96 | -32.7% | Feb 8, 2022 |
| RBC Capital | Kennen MacKay | $218 | $238.96 | -42.5% | Feb 8, 2022 |
| Cowen & Co. | Yaron Werber | $275 | $222.1 | -27.4% | Jan 27, 2022 |
| Bank of America Securities | Geoff Meacham | $255 | $223.23 | -32.7% | Jan 5, 2022 |
| Goldman Sachs | Salveen Richter | $258 | $207.02 | -31.9% | Dec 6, 2021 |
| Wolfe Research | Tim Anderson | $230 | $214.47 | -39.3% | Nov 3, 2021 |
| DZ BANK AG | Elmar Kraus | $278 | $228.31 | -26.6% | Aug 5, 2021 |
| Atlantic Equities | Steve Chesney | $200 | $229.35 | -47.2% | Apr 28, 2021 |
| Credit Suisse | Tiago Fauth | $259 | $229.35 | -31.7% | Apr 28, 2021 |
Track every rating change on AMGN the moment it posts. Free to start.
Start free